TORRENT PHARMA - short for 8% fall on weekly charts , there is a negative divergence ie price rising while MACD falling
low risk oppurtunity to short
Target and SL marked
44.15INR
12.45 BINR
95.37 BINR
96.94 M
About TORRENT PHARM
Sector
Headquarters
Ahmedabad
Employees (FY)
17.35 K
Website
Founded
1959
ISIN
INE685A01028
FIGI
BBG000D80XY7
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to local and international markets, particularly in countries such as India, USA, Germany, Brazil, and other countries. The company was founded by Uttambhai Nathalal Mehta in 1959 and is headquartered in Ahmedabad, India.
Torrent pharma is super strongTorrent pharma is growing exponentially without any break.
once it cross above 2090,
It can give a 13 to 25 % move
TORNTPHARM ROUNDING BOTTOM PATTERN IN DAILYCMP 2111.55 BUY ZONE 2090-2115 SL 2018 TGT 2349 (Positional View)
TORNTPHARM - SWING TRADE - 3rd December #stocksTORNTPHARM (1D TF)
Swing Trade Analysis given on 3rd December, 2023 (Sunday)
Pattern: NECKLINE BREAKOUT
- Trendline Breakout - Done ✓
- Retracement + Consolidation - Done ✓
#stocks #swingtrade #chartanalysis #priceaction #traderyte #torntpharm
TORNTPHARMTorrent pharma waiting for breakout 2110 level. Stok movement is good for swing trade. wait for cross and close in 4 hours. After that there is no hurdles we expect this price to reach 2270.
#TORRENT PHARMA #NSE - BREAKOUT ALERTTORRENT PHARMACEUTICALS LTD
Breaking out of a CUP pattern.
Stock at new 52 week high.
Torrent Pharmaceuticals Ltd.'s Revenue was higher than average estimate 2 times in past 3.
FII/FPI have increased holdings from 12.85% to 13.15% in Sep 2023 qtr.
Disclaimer:
For educational purpose only.
Pleas
torrent pharma long tgt 2100-2176 06-11-2023Torrent Pharam is an interesting chart with following factors
1. Ascending Triangle Breakout on Daily Chart
2. Narrowing Bollinger Bands and Price moving on upper Band
3. 20 Week SMA support at 1918-1920 zone
4. Narrowing Bollinger Bands on weekly charts
5. Daily / Weekly / Monthly all RSI above 6
torntpharma torntpharma looking strong stock consolidate higher low making good price action if daily candle close above 1950 it will give good upmove minimum 2100 then 2250
note only for educational
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TORNTPHARM is 2537.60 INR — it has increased by 0.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange TORRENT PHARM stocks are traded under the ticker TORNTPHARM.
TORRENT PHARM is going to release the next earnings report on May 28, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for TORRENT PHARM has a max estimate of 3063.00 INR and a min estimate of 2325.00 INR.
TORNTPHARM earnings for the last quarter are 11.40 INR whereas the estimation was 11.17 INR which accounts for 2.02% surprise. Estimated earnings for the next quarter are 12.31 INR. See more details about TORRENT PHARM earnings.
TORRENT PHARM revenue for the last quarter amounts to 26.60 B INR despite the estimated figure of 26.31 B INR. In the next quarter revenue is expected to reach 27.42 B INR.
Yes, you can track TORRENT PHARM financials in yearly and quarterly reports right on TradingView.
Like other stocks, TORNTPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TORRENT PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 17.35 K employees. See our rating of the largest employees — is TORRENT PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TORRENT PHARM EBITDA is 32.12 B INR, and current EBITDA margin is 29.52%. See more stats in TORRENT PHARM financial statements.